SOLAZYME INC
- Mar 24, 2016 · D · $28,750,000 sold of $28,750,000 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
- Sep 8, 2010 · D/A · $59,999,825 sold of $59,999,825 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
- Aug 9, 2010 · D · $51,549,873 sold of Indefinite · 17 investors · min. No minimum reported · role: Director EDGAR ↗
Raised $60M from 22 investors (100% of the $28.8M target) as of the latest filing. Michael is listed as director on 3 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.